Alpha Wave Global’s Alnylam Pharmaceuticals ALNY Stock Holding History

Alpha Wave Global’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-491,713	Closed	-$33.3M	–	26
2016 Q3	$33.3M	Hold	491,713	–	–	2.64%	18
2016 Q2	$27.3M	Hold	491,713	–	–	2%	18
2016 Q1	$30.9M	Hold	491,713	–	–	2.03%	21
2015 Q4	$46.3M	Hold	491,713	–	–	2.99%	13
2015 Q3	$39.5M	Sell	491,713 -46,000	-9%	-$5.11M	2.73%	12
2015 Q2	$64.5M	Sell	537,713 -334,000	-38%	-$39.9M	4.9%	9
2015 Q1	$91M	Sell	871,713 -496,000	-36%	-$50.3M	4.47%	10
2014 Q4	$133M	Buy	+1,367,713	New	+$127M	7.18%	4
2014 Q1	–	Sell	-1,000,000	Closed	-$64.3M	–	28
2013 Q4	$64.3M	Buy	+1,000,000	New	+$59.7M	4.82%	10

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Alpha Wave Global's ALNY Position: Q4 2016 in Review

Alpha Wave Global sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2016, closing a stake of 491,713 shares — an estimated $33.3M sold.

Alpha Wave Global first reported a position in ALNY in Q4 2013 and held it in 9 quarters. The position peaked at $133M in Q4 2014. 211 funds tracked by Wall St. Rank hold ALNY as of Q4 2016.

Alpha Wave Global reported no remaining Alnylam Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Alpha Wave Global sold 491,713 Alnylam Pharmaceuticals shares in Q4 2016, an estimated $33.3M.
Alpha Wave Global first reported a position in Alnylam Pharmaceuticals in Q4 2013 and held it in 9 quarters.
Alpha Wave Global's Alnylam Pharmaceuticals position peaked at $133M in Q4 2014.
211 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2016.

Based on Alpha Wave Global's 13F filing for Q4 2016, filed 14 Feb 2017.